Biocryst Pharmaceuticals reported $-43198000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Chemocentryx CCXI:US $ -22.31M 16.9M
Chugai Pharma 4519:JP Y 119689M 22673M
Daiichi Sankyo 4568:JP Y 38893M 8169M
Enanta Pharmaceuticals ENTA:US $ -33.39M 0.01M
Intra Cellular Therapies ITCI:US $ -76.93M 8.21M
IONIS PHARMACEUT IONS:US $ -84M 3M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novavax NVAX:US $ -316.39M 32.38M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
Zogenix ZGNX:US $ -58M 0.89M